Cargando…
Avoiding insufficient therapies and overdosing with co-reporting eGFRs (estimated glomerular filtration rate) for personalized drug therapy and improved outcomes – a simulation of the financial benefits
Patients with impaired renal function are at high risk for morbidity and mortality. Chronic kidney disease (CKD) even in the early stages can be associated with significant side effects of drug therapy, longer length of stay, and high costs. Correct assessment of renal function in the hospital is im...
Autores principales: | Hoenle, Adrian, Haase, Karin Johanna, Maus, Sebastian, Hofmann, Manfred, Orth, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941064/ https://www.ncbi.nlm.nih.gov/pubmed/33753973 |
Ejemplares similares
-
Evaluation of eGFRs to Calculate Kidney Function in Adults with Severe Motor and Intellectual Disabilities
por: Uemura, Osamu, et al.
Publicado: (2023) -
Molecular Docking of Phytochemicals Targeting GFRs as Therapeutic Sites for Cancer: an In Silico Study
por: Mendie, Love Edet, et al.
Publicado: (2022) -
Estimated Glomerular Filtration Rate (eGFR) Values as Predictor of Renal Insufficiency in Advanced Stages of Liver Diseases with Different Etiology
por: Vukobrat-Bijedic, Zora, et al.
Publicado: (2014) -
The glomerular filtration barrier: a structural target for novel kidney therapies
por: Daehn, Ilse S., et al.
Publicado: (2021) -
Improved estimation of glomerular filtration rate (GFR) by comparison of eGFR(cystatin C) and eGFR(creatinine)
por: Grubb, Anders, et al.
Publicado: (2012)